Flocel Inc

Flocel Inc. is a privately held biotechnology company headquartered in Cleveland, Ohio. Employing between 5 and 9 individuals, Flocel generates an estimated $50 million in annual revenue. The company was established in August 2004, building upon technology licensed from the Cleveland Clinic Foundation. Flocel specializes in developing innovative products based on its DIV-BBB technology. This technology facilitates advanced in vitro studies, enabling researchers to better understand and conduct experiments related to cell and tissue culture modeling. Flocel's products cater specifically to the research community, both within the United States and Europe. Flocel's core strength lies in its proprietary DIV-BBB technology, a three-dimensional, dynamic, in-vitro model of the blood-brain barrier. This advanced model, originally developed by Damir Janigro, Ph.D., Director of the Center for Cerebrovascular Research at The Cleveland Clinic, provides researchers with a sophisticated tool for studying the complexities of biological interactions. For more information about Flocel Inc. and its innovative products, please visit their website at flocel.com.